Cargando…

miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ET(A) receptor (ET(A)R) axis is aberrantly activated in chemoresistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Semprucci, Elisa, Di Castro, Valeriana, Caprara, Valentina, Ferrandina, Gabriella, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826186/ https://www.ncbi.nlm.nih.gov/pubmed/26675258 http://dx.doi.org/10.18632/oncotarget.6546

Ejemplares similares

Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression
por: Cianfrocca, Roberta, et al.
Publicado: (2016)

Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2020)

Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer
por: Cianfrocca, Roberta, et al.
Publicado: (2017)

β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer
por: Tocci, Piera, et al.
Publicado: (2019)

hMENA is a key regulator in endothelin-1/β-arrestin1–induced invadopodial function and metastatic process
por: Di Modugno, Francesca, et al.
Publicado: (2018)

Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
por: Tocci, Piera, et al.
Publicado: (2023)

Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2022)

YAP and endothelin-1 signaling: an emerging alliance in cancer
por: Tocci, Piera, et al.
Publicado: (2021)

Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
por: Tocci, Piera, et al.
Publicado: (2019)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer
por: Masi, Ilenia, et al.
Publicado: (2023)

Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
por: Del Rio, Danila, et al.
Publicado: (2021)

β-arrestin1 at the cross-road of endothelin-1 signaling in cancer
por: Rosanò, Laura, et al.
Publicado: (2016)

Endothelin-1 Inhibits Prolyl Hydroxylase Domain 2 to Activate Hypoxia-Inducible Factor-1α in Melanoma Cells
por: Spinella, Francesca, et al.
Publicado: (2010)

Tumor Cellular and Microenvironmental Cues Controlling Invadopodia Formation
por: Masi, Ilenia, et al.
Publicado: (2020)

Epigenetic silencing of miR-296 and miR-512 ensures hTERT dependent apoptosis protection and telomere maintenance in basal-type breast cancer cells
por: Dinami, Roberto, et al.
Publicado: (2017)

Endothelin receptors as novel targets in tumor therapy
por: Bagnato, Anna, et al.
Publicado: (2004)

Astrocyte elevated gene-1 regulates osteosarcoma cell invasion and chemoresistance via endothelin-1/endothelin A receptor signaling
por: LIU, BO, et al.
Publicado: (2013)

Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
por: Cioce, Mario, et al.
Publicado: (2014)

Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
por: Anggorowati, Nungki, et al.
Publicado: (2018)

Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature
por: Cioce, Mario, et al.
Publicado: (2021)

Contribution of TIP30 to chemoresistance in laryngeal carcinoma
por: Zhu, M, et al.
Publicado: (2014)

Salivary miR-30c-5p as Potential Biomarker for Detection of Oral Squamous Cell Carcinoma
por: Mehterov, Nikolay, et al.
Publicado: (2021)

Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ET(A) Receptor
por: Maffei, Rossana, et al.
Publicado: (2014)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Endothelin
por: Davenport, Anthony P., et al.
Publicado: (2016)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
por: Dar, Sajad, et al.
Publicado: (2017)

Bevacizumab as adjunct to chemotherapy for chemoresistant ovarian cancer
por: Hamilton, Gerhard
Publicado: (2020)

Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014)

Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19
por: Sanghavi, Devang K., et al.
Publicado: (2021)

New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
por: Bagnato, Anna, et al.
Publicado: (2019)

MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014)

Chemoresistance in human ovarian cancer: the role of apoptotic regulators
por: Fraser, Michael, et al.
Publicado: (2003)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blkf1gs3uv9f9v7lnunknk9ph4